Protara Therapeutics
ArTara Therapeutics is a Biotechnology company.
Launch date
Employees
Market cap
€35.3m
Enterprise valuation
(€42m) (Public information from Sep 2024)
Share price
$1.97 TARA
New York City New York (HQ)
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | - | - | - | - | - | - | 1.1m |
EBITDA | (21.3m) | (15.2m) | (34.2m) | (47.3m) | (8.0m) | (43.3m) | - |
Profit | (20.7m) | (15.0m) | (34.0m) | (47.3m) | (66.0m) | (40.4m) | - |
R&D budget | 11.8m | 6.4m | 12.0m | 21.1m | 16.8m | 25.0m | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | $4.2m | Post IPO Equity | |
* | $45.0m | Private Placement VC | |
Total Funding | €40.9m |
Recent News about Protara Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.